Comprehensive Organoid and Organ-on-Chip Solutions
From custom design to functional characterization, our Organoid & Organ-on-Chip services are designed to provide highly predictive in vitro models and testing to meet the most advanced needs of your drug discovery, safety assessment and disease modeling projects.
Contact Us for a Free Consultation
Our Organoid & Organ-on-Chip Services
- Model Development
- Pharmacology & DMPK
- Analytical & Readout
Model Development
Use our technical expertise to develop custom or off-the-shelf advanced in vitro models to suit your project needs.

Organoid Model Development
Custom generation and scale-up of 3D patient-derived or iPSC-derived organoids (e.g., gut, liver, lung, brain, kidney).

Organ-on-Chip Development
Integration of single organoids/tissue structures into microfluidic chips for dynamic culture, controlled flow, and mechanical stimulation.

Multi-Organ-Chip Development
Engineering and interconnection of multiple organ-on-chip units (e.g., Liver-Gut-Kidney axis) to study systemic drug effects and inter-organ communication.
Pharmacology & DMPK
Utilize our complex Organoid and Organ-on-Chip models for highly predictive functional and safety testing.
Analytical & Readout Services
We provide robust analytical support, offering advanced functional assays, high-content imaging, and multi-omics analysis to deliver deep mechanistic insights from your organoid and Organ-on-Chip experiments.
- Imaging
- Molecular Analysis
- Functional Assays
- Omics Services

Highlighted Capabilities
Human-Relevant Modeling
Advanced 3D organoids and dynamic organ-on-chip systems that closely recapitulate native human physiology.
Integrated Platform Approach
Seamless connection of organoids, microfluidic chips, and multi-organ circuits for systemic-level insights.
Scalability & Automation
Services are optimized for high-throughput screening (HTS) and automation, supporting both early discovery and large-scale compound evaluation.
Customizable & Scalable Solutions
Tailored model development and high-throughput screening capabilities for diverse research needs.
FAQ

How long can organoids or organ-on-chip models be maintained in culture?
Typically from weeks to months depending on the tissue and study design; organ-on-chip can also support much longer durations under microfluidic perfusion. Chronic studies such as repeated dose toxicity or disease progression are well within the capabilities.
Can your models be customized for specific disease or mechanism studies?
Yes. Our platforms support extensive customization, including genetic modification, patient-derived models, microenvironment tuning, multi-cell-type integration, and disease-specific stimuli. We can work with clients to adapt our models to their specific disease mechanism of interest or target pathway/drug target.
What assays and readouts are compatible with your technology platforms?
Our platforms support the full range of high-throughput cell-based assays, including viability/toxicity, biomarker expression, imaging-based phenotyping, metabolic profiling, transcriptomics, and many others, such as electrophysiology and functional readouts such as barrier function or transport studies. High-content imaging and multi-omics profiling are also supported.
How do I get started on a project or request a consultation?
Just email our technical team through the website with your research needs or study goals and we will assist in designing a suitable model and workflow along with a project plan to match.




